N/A
Completed N=120
Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease
CKD - Chronic Kidney Disease
Source: ClinicalTrials.gov NCT06065501 ↗
Enrolled (actual)
120
Serious AEs
0.8%
Results posted
Jun 2025
Primary outcomePrimary: Tilburg Frailty Indicator (TFI) — 5.38; 4.97; 4.16; 4.16 score on a scale
Summary
This is a randomized controlled trial study conducted on frail patients with chronic kidney disease(CKD).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Tilburg Frailty Indicator (TFI) |
5.38; 4.97; 4.16; 4.16; 4.43; 4.74 | — |
| SECONDARY Physical Activity Level Measured by IPAQ-Taiwan |
3650.88; 3971.91; 3248.18; 3891.37; 3588.53; 3259.35 | — |
| SECONDARY Health-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version) |
149; 144.6; 152.93; 149.60; 149.81; 142.46 | — |
| SECONDARY Nutritional Status Measured by MNA-SF |
12.25; 12.55; 12.49; 12.59; 12.42; 12.35 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosed with CKD stage 1 to 5
- Participants with pre-frail and frail conditions.
- Having access to a mobile phone and is capable of using mobile social network application (Line)
Exclusion Criteria
- Received renal replacement therapy
- Participants achieved TTM stage 5
Data sourced from ClinicalTrials.gov (NCT06065501). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.